EW News and Press, Edwards Lifesciences Corporation From 02/19/19

Merger activity decreased last week with two new deals announced and five pending deals closing. Deal Statistics: New Deals: The acquisition of Ellie Mae (ELLI) by Thoma Bravo for $3.7 billion or $99.00 per share in cash. The acquisition of CAS Medical Systems (CASM) by Edwar...

The FDA has issued draft guidance for medical device makers on how to request nonbinding feedback on certain kinds of Form 483 deficiencies noted during on-site inspections. The objective is to enable them address the issues in a more timely and consistent fashion. Previously, companies co...

Edwards Lifesciences (NYSE: EW ) has agreed to acquire CAS Medical Systems (NASDAQ: CASM ) for $2.45 per share ($100M) in cash. More news on: Edwards Lifesciences Corp, CAS Medical Systems, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more ......

IRVINE, Calif. and BRANFORD, Conn. , Feb. 12, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has entered into a definitive merger a...

Detailed Research: Economic Perspectives on Edwards Lifesciences, Zimmer Biomet, American Outdoor Br, Feb. 06, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, a...

Edwards Lifesciences Corp (EW) Q4 2018 Results Conference Call January 31, 2018 00:00 AM ET Company Participants David Erickson - Vice President, Investor Relations Mike Mussallem - Chairman and CEO Scott Ullem - CFO Conference Call Participants Bob Hopkins - Bank of Americ...

Edwards Lifesciences (NYSE: EW ) Q4 results ($M): Total sales: 977.7 (+10.0%); Transcatheter heart valves: 592.4 (+14.1%); Surgical Heart Valves: 207.2 (+1.1%); Critical Care: 178.1 (+8.4%). More news on: Edwards Lifesciences Corp, Healthcare stocks news, Earnings news and commentary, St...

Edwards Lifesciences (NYSE: EW ): Q4 Non-GAAP EPS of $1.17 in-line; GAAP EPS of $0.03 misses by $1.14 . Revenue of $977.7M (+10.0% Y/Y) beats by $1.38M . Press Release More news on: Edwards Lifesciences Corp, Earnings news and commentary, Healthcare stocks news,

IRVINE, Calif. , Jan. 31, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended December 31, 2018. ...

AFL , AJG , AMZN , CLS , CPT , CY , DECK , EMN , ENVA , EPAY , ESL , EW , EXPO , FBHS , KLIC , LPLA , MATW , MCK , MTX , NFG , OTEX , PFPT , PKI , POST , SIGI , SKYW , SYMC , WAIR , YUMC For Seeking Alpha's full earnings season calendar, click here . More...